GNC Holdings (GNC) to Coninue Selling Stimulant DMAA - CNBC

GNC Holdings (NYSE: GNC) is seeing some activity on headlines from CNBC that it will continue to sell products containing DMAA. It was reported earlier that the U.S. FDA sent warnings letters to 10 companies who produce DMAA and products from the stimulant for not properly following safety protocol.

For more on the report, click here.

GNC is now about 5.4 percent lower, off of intraday lows.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Alumis SLE trial fails primary endpoints; subgroup data guides Phase 3
• FDA accepts United Therapeutics' drug application for IPF treatment
• MIRA Pharmaceuticals reports positive toxicology data for MIRA-55 pain drug